Orgenesis Inc. in brief
Orgenesis Inc. is a listed company in the Biotechnology industry, based in the USA. Its last known market value was $15 M (January 2024); there is no current figure. In its latest reported year it had sales of $8 M and a net profit of $6 M, about 82 cents of profit for every dollar of sales. Its shares trade under the symbol ORGS (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Market cap history
World rank over time
Rank in USA: #3,888 (Jan 2020) · #3,637 (Jan 2021) · #4,763 (Jan 2022) · #4,924 (Dec 2022) · #5,009 (Jul 2023) · #4,432 (Jan 2024)
Annual results
- Revenue
- $8 M
- Operating income
- —
- Net income
- $6 M
Markets and events: Orgenesis Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Fails to deliver
- : 100 shares at $1.00
- : 759 shares at $1.33
- : 821 shares at $1.53
- : 761 shares at $1.53
- : 8 shares at $2.27
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
How Orgenesis Inc. compares in Biotechnology
- Revenue$8 M · higher than 39% of 647
- Net margin81.6% · higher than 99% of 408
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Orgenesis Inc.🇺🇸 | $15 M | — | 81.6% | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Profile updated:
- Nov 4, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Orgenesis Inc.? Verify and update this profile — free
Show Orgenesis Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.